CIK 0001770069
- Emerging growth company
MapLight Therapeutics, Inc.
Sign in to watch- Ticker
- MPLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 832163243
- Phone
- +1 617-984-6300
- Business address
- 800 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- Alvarado Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,256,232
- in 7 filings, $193K under 10b5-1 plans
Net −$1,256,232. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Kroeger Christopher A. −$595K Chief Executive Officer sold 6% of stake
- Hanson Kristopher −$266K General Counsel sold 17% of stake
- Foff Erin Pennock −$124K Chief Medical Officer sold 5% of stake
- Kreitzer Anatol −$96K Chief Discovery Officer sold 7% of stake
- Lillie James Woodruff −$93K Chief Scientific Officer sold 5% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-15 | Kroeger Christopher A. Chief Executive Officer | Sale | −73,691 | $8.08 | $595K | 1,195,909 |
| 2026-08-17 | Kroeger Christopher A. Chief Executive Officer | Grant or award | +23,145 | 1,269,600 | ||
| 2026-08-17 | Kroeger Christopher A. Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +93,955 | 93,955 | ||
| 2026-07-17 | Kroeger Christopher A. Chief Executive Officer | Sale | −16,779 | $37.90 | $636K | 1,246,455 |
| 2026-07-16 | Kroeger Christopher A. Chief Executive Officer | Sale | −40,899 | $36.46 | $1.5M | 1,291,417 |
| 2026-07-16 | Kroeger Christopher A. Chief Executive Officer | Sale | −28,091 | $37.26 | $1.0M | 1,263,326 |
| 2026-07-16 | Kroeger Christopher A. Chief Executive Officer | Sale | −92 | $37.96 | $3K | 1,263,234 |
| 2026-07-15 | Kroeger Christopher A. Chief Executive Officer | Sale | −18,950 | $36.00 | $682K | 1,375,144 |
| 2026-07-15 | Kroeger Christopher A. Chief Executive Officer | Sale | −42,738 | $36.99 | $1.6M | 1,332,406 |
| 2026-07-15 | Kroeger Christopher A. Chief Executive Officer | Sale | −90 | $37.54 | $3K | 1,332,316 |
| 2026-05-18 | Kroeger Christopher A. Chief Executive Officer | Sale 10b5-1 | −118,037 | $27.19 | $3.2M | 1,394,292 |
| 2026-05-18 | Kroeger Christopher A. Chief Executive Officer | Sale 10b5-1 | −198 | $28.15 | $6K | 1,394,094 |
| 2026-05-11 | Kroeger Christopher A. Chief Executive Officer | Sale 10b5-1 | −342 | $27.57 | $9K | 1,525,967 |
| 2026-05-11 | Kroeger Christopher A. Chief Executive Officer | Sale 10b5-1 | −877 | $28.70 | $25K | 1,525,090 |
| 2026-05-11 | Kroeger Christopher A. Chief Executive Officer | Sale 10b5-1 | −6,871 | $30.04 | $206K | 1,518,219 |
| 2026-05-11 | Kroeger Christopher A. Chief Executive Officer | Sale 10b5-1 | −5,890 | $30.56 | $180K | 1,512,329 |
| 2026-05-08 | Kroeger Christopher A. Chief Executive Officer | Sale 10b5-1 | −29,624 | $27.48 | $814K | 1,531,096 |
| 2026-05-08 | Kroeger Christopher A. Chief Executive Officer | Sale 10b5-1 | −1,582 | $28.56 | $45K | 1,529,514 |
| 2026-05-08 | Kroeger Christopher A. Chief Executive Officer | Sale 10b5-1 | −3,205 | $29.20 | $94K | 1,526,309 |
| 2026-05-07 | Kroeger Christopher A. Chief Executive Officer | Sale 10b5-1 | −14,880 | $28.47 | $424K | 1,565,940 |
Page 1 of 2 · 39 trades